Imaging News

ATLANTA — A screening study presented at the American College of Cardiology Scientific Session showed that there is a high prevalence of unrecognized heart disease among former National Football League players.

The 2024 American College of Cardiology Scientific Session will be held live in Atlanta from April 6 to 8 and virtually, with 43 late-breaking trials and featured clinical research presentations.

Artificial intelligence analysis of a single chest radiograph may predict 10-year CVD risk beyond the traditional atherosclerotic CVD risk calculator, even among individuals with missing electronic medical record data, researchers reported.

More than 20% of reported cases of adverse events following bispecific T-cell engager therapies involved a cardiovascular event, findings reported in Journal for ImmunoTherapy of Cancer showed.

The nature of the relationship between discrimination, smoking and features of CVD is complex and varies by race and sex, according to a moderated mediation analysis published in the Journal of the American Heart Association.

Cleerly has received FDA breakthrough device designation for its coronary artery disease staging system, which was also accepted into the FDA’s Total Product Life Cycle Advisory Program Pilot, according to a company press release.

Echocardiographic data show that physiological adaptation due to sporting activity can cause increased right heart size for adolescent boys, researchers reported.

The combination of abnormal baseline global longitudinal strain and N-terminal-pro-B-type natriuretic peptide is associated with a more than fourfold risk for subsequent cardiomyopathy among certain childhood cancer survivors.

Among patients with stable chest pain referred for invasive coronary angiography, a low coronary artery calcium score was associated with low risk for heart attack and stroke, researchers reported in Radiology.

Lantheus Holdings announced the FDA has approved the supplemental new drug application for its perflutren lipid microsphere injection to improve ultrasound imaging in pediatric patients with suboptimal echocardiograms.